住院治疗COVID-19后的大脑干神经化学特征:一个7T MR光谱学研究
Carina Graf1, Betty Raman2, Anne Manktelow3
1Wolfson Brain Imaging Centre, Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom.
Frontiers in neuroscience
|October 31, 2025
概括
这项研究探讨了使用7T MRS的COVID-19幸存者的脑干神经化学. 虽然炎症与肌肉内醇和症状相关,但在患者和对照组之间没有发现显著差异.
科学领域:
- 神经科学是一个神经科学.
- 医疗成像医学成像
- 传染性疾病 传染性疾病
背景情况:
- 严重急性呼吸系统综合征冠状病毒2 (SARS-CoV-2) 感染,或COVID-19,与大量住院患者的持续体力,认知和心理健康问题有关.
- 这些后急性后果的神经解剖学基础在很大程度上是未知的,新出现的证据表明改变了脑干生理学.
- 调查脑干神经化学概况可能为长期COVID的病理生理学提供见解.
研究的目的:
- 为了测试这个假设,脑干神经化学概况在因COVID-19而住院的个人和匹配的健康对照人之间有所不同.
- 利用先进的7特斯拉 (7T) 磁共振光谱 (MRS) 来评估这些神经化学差异.
- 为了将发现与COVID-19严重性标志物相关联.
主要方法:
- 一项前性病例控制研究,涉及34名COVID-19患者和15名健康对照.
- 通过adiabatic选择性重定位 (sLASER) 进行7T半adiabatic定位1H-MRS在点髓交叉点进行.
- 代谢物度在各组之间进行了比较,并使用线性混合建模与最大C反应蛋白 (CRPmax) 和患者报告的症状相关联.
主要成果:
- 大多数参与者 (44/49) 获得了高光谱质量.
- 在炎症大小 (CRPmax) 和肌肉内醇度 (p=0.035) 之间观察到正相关性.
- 患者报告的症状也与肌肉内醇水平相关 (p=0.023),但在COVID-19患者和对照人群之间没有发现代谢物度的显著差异.
结论:
- 这项研究证明了多中心7T 1H-MRS用于评估脑干神经化学的可行性.
- 技术限制,如可变的重复时间,影响了统计能力,应该在未来的研究中加以解决.
- 进一步调查神经炎症在后急性COVID-19中的作用是有必要的.
更多相关视频
09:01Metabolomic Analysis of Rat Brain by High Resolution Nuclear Magnetic Resonance Spectroscopy of Tissue Extracts
Published on: September 21, 2014
15.2K
05:52Early Pathological and Magnetic Resonance Detection of Cerebral Injury Using a Rat Model of Neonatal Hypoxic Ischemic Encephalopathy
Published on: October 28, 2022
1.0K
相关概念视频
Magnetic Resonance Imaging
Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...
Brain Imaging
Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic Stimulation (TMS).
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic Stimulation (TMS).
